LRC-TriCEPS Service

«Leveraging Dualsystems Biotech novel linker technology (LRC-TriCEPS) and its analytical data processing capabilities we were able to identify the heterophilic receptor for a highly-pursued immuno-oncology target.» Igenica-Biotherapeutics-logo Dr. Edward van der Horst, Senior Director, Preclinical Development Igenica Biotherapeutics
2016-05-09T11:13:08+00:00